ID   HACD1_HUMAN             Reviewed;         288 AA.
AC   B0YJ81; B0YJ80; Q6JIC5; Q96FW7; Q9HB93; Q9UHX2;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   08-APR-2008, sequence version 1.
DT   10-MAY-2017, entry version 81.
DE   RecName: Full=Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1 {ECO:0000305};
DE            EC=4.2.1.134 {ECO:0000269|PubMed:18554506, ECO:0000269|PubMed:23933735};
DE   AltName: Full=3-hydroxyacyl-CoA dehydratase 1 {ECO:0000303|PubMed:18554506};
DE            Short=HACD1 {ECO:0000303|PubMed:15164054};
DE   AltName: Full=Cementum-attachment protein {ECO:0000303|PubMed:22067203};
DE            Short=CAP {ECO:0000303|PubMed:22067203};
DE   AltName: Full=Protein-tyrosine phosphatase-like member A {ECO:0000312|HGNC:HGNC:9639};
GN   Name=HACD1 {ECO:0000303|PubMed:15164054, ECO:0000312|HGNC:HGNC:9639};
GN   Synonyms=PTPLA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS LYS-64; GLN-64; PHE-70 AND
RP   TYR-227, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=11054553; DOI=10.1016/S0378-1119(00)00347-4;
RA   Li D., Gonzalez O., Bachinski L.L., Roberts R.;
RT   "Human protein tyrosine phosphatase-like gene: expression profile,
RT   genomic structure, and mutation analysis in families with ARVD.";
RL   Gene 256:237-243(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS LYS-64 AND
RP   TYR-227.
RX   PubMed=10644438; DOI=10.1006/geno.1999.5950;
RA   Uwanogho D.A., Hardcastle Z., Balogh P., Mirza G., Thornburg K.L.,
RA   Ragoussis J., Sharpe P.T.;
RT   "Molecular cloning, chromosomal mapping, and developmental expression
RT   of a novel protein tyrosine phosphatase-like gene.";
RL   Genomics 62:406-416(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION (ISOFORM 2), AND
RP   TISSUE SPECIFICITY.
RX   PubMed=22067203; DOI=10.1177/0022034511428155;
RA   Valdes De Hoyos A., Hoz-Rodriguez L., Arzate H., Narayanan A.S.;
RT   "Isolation of protein-tyrosine phosphatase-like member-a variant from
RT   cementum.";
RL   J. Dent. Res. 91:203-209(2012).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   LYS-64 AND PHE-70.
RC   TISSUE=Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 5-288 (ISOFORM 1).
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, CATALYTIC ACTIVITY, PATHWAY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=18554506; DOI=10.1016/j.febslet.2008.06.007;
RA   Ikeda M., Kanao Y., Yamanaka M., Sakuraba H., Mizutani Y.,
RA   Igarashi Y., Kihara A.;
RT   "Characterization of four mammalian 3-hydroxyacyl-CoA dehydratases
RT   involved in very long-chain fatty acid synthesis.";
RL   FEBS Lett. 582:2435-2440(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   INVOLVEMENT IN CFTD, GLYCOSYLATION, AND CATALYTIC ACTIVITY.
RX   PubMed=23933735; DOI=10.1093/hmg/ddt380;
RA   Muhammad E., Reish O., Ohno Y., Scheetz T., Deluca A., Searby C.,
RA   Regev M., Benyamini L., Fellig Y., Kihara A., Sheffield V.C.,
RA   Parvari R.;
RT   "Congenital myopathy is caused by mutation of HACD1.";
RL   Hum. Mol. Genet. 22:5229-5236(2013).
RN   [11]
RP   FUNCTION (ISOFORM 2), AND SUBUNIT (ISOFORM 2).
RX   PubMed=25263524; DOI=10.1016/j.bone.2014.09.014;
RA   Montoya G., Arenas J., Romo E., Zeichner-David M., Alvarez M.,
RA   Narayanan A.S., Velazquez U., Mercado G., Arzate H.;
RT   "Human recombinant cementum attachment protein (hrPTPLa/CAP) promotes
RT   hydroxyapatite crystal formation in vitro and bone healing in vivo.";
RL   Bone 69:154-164(2014).
CC   -!- FUNCTION: Isoform 1: Catalyzes the third of the four reactions of
CC       the long-chain fatty acids elongation cycle. This endoplasmic
CC       reticulum-bound enzymatic process, allows the addition of two
CC       carbons to the chain of long- and very long-chain fatty
CC       acids/VLCFAs per cycle. This enzyme catalyzes the dehydration of
CC       the 3-hydroxyacyl-CoA intermediate into trans-2,3-enoyl-CoA,
CC       within each cycle of fatty acid elongation. Thereby, it
CC       participates in the production of VLCFAs of different chain
CC       lengths that are involved in multiple biological processes as
CC       precursors of membrane lipids and lipid mediators.
CC       {ECO:0000269|PubMed:18554506}.
CC   -!- FUNCTION: Isoform 2: In tooth development, may play a role in the
CC       recruitment and the differentiation of cells that contribute to
CC       cementum formation. May also bind hydroxyapatite and regulate its
CC       crystal nucleation to form cementum.
CC       {ECO:0000269|PubMed:22067203}.
CC   -!- CATALYTIC ACTIVITY: A very-long-chain (3R)-3-hydroxyacyl-CoA = a
CC       very-long-chain trans-2,3-dehydroacyl-CoA + H(2)O.
CC       {ECO:0000269|PubMed:18554506, ECO:0000269|PubMed:23933735}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=33.6 uM for 3-hydroxypalmitoyl-CoA (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:18554506};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000269|PubMed:18554506}.
CC   -!- SUBUNIT: Isoform 1: May interact with enzymes of the ELO family
CC       (including ELOVL1); with those enzymes that mediate condensation,
CC       the first of the four steps of the reaction cycle responsible for
CC       fatty acids elongation, may be part of a larger fatty acids
CC       elongase complex (PubMed:18554506). Isoform 2: Homooligomer. Self-
CC       assembles into spheres which then aggregates to form strings and a
CC       meshwork that may support hydroxyapatite crystal nucleation
CC       (PubMed:25263524). {ECO:0000269|PubMed:18554506,
CC       ECO:0000269|PubMed:25263524}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:18554506}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:18554506}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=B0YJ81-1; Sequence=Displayed;
CC       Name=2; Synonyms=CAP, cementum-attachment protein, PTPLA-CAP
CC       {ECO:0000303|PubMed:22067203};
CC         IsoId=B0YJ81-2; Sequence=VSP_035363, VSP_035364;
CC         Note=Catalytically inactive since it lacks the active site but
CC         may have an alternative function. {ECO:0000269|PubMed:22067203};
CC   -!- TISSUE SPECIFICITY: Isoform 1 is highly expressed in the
CC       myocardium, and to a lesser extent in skeletal and smooth muscular
CC       tissues including those from stomach, jejunum, and bladder. Also
CC       detected in gingival fibroblasts, periodontal ligament cells,
CC       osteoblasts and cementoblasts (PubMed:11054553, PubMed:22067203).
CC       Isoform 2 is specifically expressed by cementoblasts but also
CC       detected in periodontal ligament cells, heart, liver and kidney
CC       (at protein level) (PubMed:22067203).
CC       {ECO:0000269|PubMed:11054553, ECO:0000269|PubMed:22067203}.
CC   -!- DEVELOPMENTAL STAGE: Isoform 1 is expressed in fetal heart.
CC       {ECO:0000269|PubMed:11054553}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:23933735}.
CC   -!- DISEASE: Myopathy, congenital, with fiber-type disproportion
CC       (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which
CC       there is relative hypotrophy of type 1 muscle fibers compared to
CC       type 2 fibers on skeletal muscle biopsy. However, these findings
CC       are not specific and can be found in many different myopathic and
CC       neuropathic conditions. {ECO:0000269|PubMed:23933735}. Note=The
CC       gene represented in this entry may be involved in disease
CC       pathogenesis. A loss-of-function mutation that segregates with the
CC       disease was found in four members of a consanguineous family and
CC       not identified in unaffected controls. The mutation affects the
CC       expression of the mRNA and the produced protein is catalytically
CC       inactive. {ECO:0000269|PubMed:23933735}.
CC   -!- SIMILARITY: Belongs to the very long-chain fatty acids dehydratase
CC       HACD family. {ECO:0000305}.
CC   -!- CAUTION: Isoform 1 shares some similarity with tyrosine
CC       phosphatase proteins but it has probably no phosphatase activity.
CC       {ECO:0000250|UniProtKB:Q6Y1H2, ECO:0000305|PubMed:18554506}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG10713.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=ACA06059.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF266852; AAG10713.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AF266848; AAG10713.1; JOINED; Genomic_DNA.
DR   EMBL; AF266849; AAG10713.1; JOINED; Genomic_DNA.
DR   EMBL; AF266850; AAG10713.1; JOINED; Genomic_DNA.
DR   EMBL; AF266851; AAG10713.1; JOINED; Genomic_DNA.
DR   EMBL; AF114494; AAF21976.1; -; mRNA.
DR   EMBL; AY455942; AAR22554.1; -; mRNA.
DR   EMBL; EF445016; ACA06059.1; ALT_INIT; Genomic_DNA.
DR   EMBL; EF445016; ACA06060.1; -; Genomic_DNA.
DR   EMBL; EF445016; ACA06061.1; -; Genomic_DNA.
DR   EMBL; AC069542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC010353; AAH10353.1; -; mRNA.
DR   EMBL; CR608689; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS7121.1; -. [B0YJ81-1]
DR   RefSeq; NP_055056.3; NM_014241.3. [B0YJ81-1]
DR   UniGene; Hs.114062; -.
DR   ProteinModelPortal; B0YJ81; -.
DR   BioGrid; 114634; 4.
DR   IntAct; B0YJ81; 2.
DR   STRING; 9606.ENSP00000355308; -.
DR   SwissLipids; SLP:000000435; -.
DR   iPTMnet; B0YJ81; -.
DR   PhosphoSitePlus; B0YJ81; -.
DR   BioMuta; PTPLA; -.
DR   EPD; B0YJ81; -.
DR   MaxQB; B0YJ81; -.
DR   PaxDb; B0YJ81; -.
DR   PRIDE; B0YJ81; -.
DR   DNASU; 9200; -.
DR   Ensembl; ENST00000361271; ENSP00000355308; ENSG00000165996. [B0YJ81-1]
DR   GeneID; 9200; -.
DR   KEGG; hsa:9200; -.
DR   UCSC; uc001ipg.4; human. [B0YJ81-1]
DR   CTD; 9200; -.
DR   DisGeNET; 9200; -.
DR   GeneCards; HACD1; -.
DR   H-InvDB; HIX0008683; -.
DR   HGNC; HGNC:9639; HACD1.
DR   MalaCards; HACD1; -.
DR   MIM; 255310; phenotype.
DR   MIM; 610467; gene.
DR   neXtProt; NX_B0YJ81; -.
DR   OpenTargets; ENSG00000165996; -.
DR   Orphanet; 2020; Congenital fiber-type disproportion myopathy.
DR   PharmGKB; PA33982; -.
DR   eggNOG; KOG3187; Eukaryota.
DR   eggNOG; COG5198; LUCA.
DR   GeneTree; ENSGT00530000062962; -.
DR   HOGENOM; HOG000190538; -.
DR   HOVERGEN; HBG057518; -.
DR   InParanoid; B0YJ81; -.
DR   KO; K10703; -.
DR   OMA; GTHRGLY; -.
DR   OrthoDB; EOG091G0Q7P; -.
DR   PhylomeDB; B0YJ81; -.
DR   TreeFam; TF313326; -.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   UniPathway; UPA00094; -.
DR   GenomeRNAi; 9200; -.
DR   PRO; PR:B0YJ81; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000165996; -.
DR   CleanEx; HS_PTPLA; -.
DR   ExpressionAtlas; B0YJ81; baseline and differential.
DR   Genevisible; B0YJ81; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0102344; F:3-hydroxy-behenoyl-CoA dehydratase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102345; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; IEA:UniProtKB-EC.
DR   GO; GO:0018812; F:3-hydroxyacyl-CoA dehydratase activity; IDA:UniProtKB.
DR   GO; GO:0080023; F:3R-hydroxyacyl-CoA dehydratase activity; EXP:Reactome.
DR   GO; GO:0019899; F:enzyme binding; IDA:UniProtKB.
DR   GO; GO:0046848; F:hydroxyapatite binding; IDA:UniProtKB.
DR   GO; GO:0034622; P:cellular macromolecular complex assembly; IDA:UniProtKB.
DR   GO; GO:0071529; P:cementum mineralization; IDA:UniProtKB.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0030497; P:fatty acid elongation; IDA:UniProtKB.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IDA:UniProtKB.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; IGI:UniProtKB.
DR   GO; GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB.
DR   InterPro; IPR007482; Tyr_Pase-like_PTPLA.
DR   PANTHER; PTHR11035; PTHR11035; 1.
DR   Pfam; PF04387; PTPLA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   Endoplasmic reticulum; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Glycoprotein; Lipid biosynthesis; Lipid metabolism; Lyase; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    288       Very-long-chain (3R)-3-hydroxyacyl-CoA
FT                                dehydratase 1.
FT                                /FTId=PRO_0000349315.
FT   TOPO_DOM      1     75       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     76     95       Helical. {ECO:0000255}.
FT   TOPO_DOM     96    114       Lumenal. {ECO:0000255}.
FT   TRANSMEM    115    131       Helical. {ECO:0000255}.
FT   TOPO_DOM    132    141       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    142    159       Helical. {ECO:0000255}.
FT   TOPO_DOM    160    165       Lumenal. {ECO:0000255}.
FT   TRANSMEM    166    180       Helical. {ECO:0000255}.
FT   TOPO_DOM    181    203       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    204    221       Helical. {ECO:0000255}.
FT   TOPO_DOM    222    251       Lumenal. {ECO:0000255}.
FT   TRANSMEM    252    269       Helical. {ECO:0000255}.
FT   TOPO_DOM    270    288       Cytoplasmic. {ECO:0000255}.
FT   ACT_SITE    210    210       {ECO:0000250|UniProtKB:P40857}.
FT   ACT_SITE    217    217       {ECO:0000250|UniProtKB:P40857}.
FT   MOD_RES      22     22       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   CARBOHYD    243    243       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     126    140       IVHCLIGIVPTSVIV -> VSFPSCCFSIAVIFM (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:22067203}.
FT                                /FTId=VSP_035363.
FT   VAR_SEQ     141    288       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:22067203}.
FT                                /FTId=VSP_035364.
FT   VARIANT      64     64       E -> K (in dbSNP:rs7895850).
FT                                {ECO:0000269|PubMed:10644438,
FT                                ECO:0000269|PubMed:11054553,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_046366.
FT   VARIANT      64     64       E -> Q (in dbSNP:rs7895850).
FT                                {ECO:0000269|PubMed:11054553}.
FT                                /FTId=VAR_046367.
FT   VARIANT      70     70       V -> F (in dbSNP:rs11254692).
FT                                {ECO:0000269|PubMed:11054553,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_046368.
FT   VARIANT     227    227       H -> Y (in dbSNP:rs1053926).
FT                                {ECO:0000269|PubMed:10644438,
FT                                ECO:0000269|PubMed:11054553}.
FT                                /FTId=VAR_046369.
FT   CONFLICT     80     80       D -> N (in Ref. 2; AAF21976).
FT                                {ECO:0000305}.
SQ   SEQUENCE   288 AA;  32388 MW;  1CB64F23C3907F6E CRC64;
     MGRLTEAAAA GSGSRAAGWA GSPPTLLPLS PTSPRCAATM ASSDEDGTNG GASEAGEDRE
     APGERRRLGV LATAWLTFYD IAMTAGWLVL AIAMVRFYME KGTHRGLYKS IQKTLKFFQT
     FALLEIVHCL IGIVPTSVIV TGVQVSSRIF MVWLITHSIK PIQNEESVVL FLVAWTVTEI
     TRYSFYTFSL LDHLPYFIKW ARYNFFIILY PVGVAGELLT IYAALPHVKK TGMFSIRLPN
     KYNVSFDYYY FLLITMASYI PLFPQLYFHM LRQRRKVLHG EVIVEKDD
//
